ALung Technologies (Pittsburgh) said it has closed on a new financing of about $10 million from new and existing investors. The proceeds will primarily support ongoing commercialization of the company's Hemolung respiratory assist system (RAS), a low-flow, minimally invasive ECO2R system. Read More
